Raw-Journal Peptide Science | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

All posts in Raw-Journal Peptide Science

Cationic heterooligopeptides by ficain-catalyzed co-oligomerization of lysine and methionine ethylesters

Oligopeptides are of high importance for various industrial applications, e.g. cosmetical or medical. Homooligomerizations and co-oligomerizations with anionic amino acid esters are well described but a successful synthesis of cationic heterooligopeptides has been missing so far. The present study reports the ficain-catalyzed heterooligomerizations of LysOEt with MetOEt, leading to cationic heterooligopeptides with a yield up to 49.5% (w/w). MALDI-ToF/ToF-MS analyses proved successful syntheses of cationic heterooligopeptides with a DP between 7 and 10 amino acid residues, with the enzyme exhibiting a clear preference for methionine. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

The present study reports the ficain-catalyzed heterooligomerizations of H-Lys-OEt with H-Met-OEt. MALDI-ToF/ToF-MS analyses proved successful syntheses of cationic heterooligopeptides with a degree of polymerization between 7 and 10 amino acid residues, with the enzyme exhibiting a clear preference for methionine.

Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington’s disease

Huntington's and eight other neurodegenerative diseases occur because of CAG repeat expansion mutation culminating into an expanded polyglutamine tract in respective protein. In Huntington's disease (HD), a number of CAG repeats beyond normal repeat length (>36) lead to the formation of mutant protein, the proteolytic cleavage of which induces aggregation in polyglutamine length-dependent manner. The neurodegeneration in this disease is linked to aggregation, and its inhibition is a potential approach for therapeutic development. Although peptides and other molecules have been developed for inhibiting aggregation, peptides in general are susceptible to degradation in vivo conditions. To understand their clinical significance, they also need to be delivered through blood–brain barrier. Here, for the first time, we have synthesized poly-d,l-lactide-co-glycolide nanoparticles containing a polyglutamine aggregation inhibitor peptide PGQ9[P2], by nanoprecipitation method. This process yielded less than 200 nm spherical nanoparticles with uniform distribution. Characterization studies by infrared spectroscopy-based and HPLC-based assays show the presence of PGQ9[P2] in nanoparticles. In vitro release kinetics demonstrates that nanoparticles release PGQ9[P2] by erosion and diffusion processes. When the PGQ9[P2]-loaded nanoparticles are incubated with aggregation-prone Q35P10 peptide, representing N-terminal part of Huntingtin protein, it arrests the elongation phase of Q35P10 aggregation. These findings propose the first step toward delivery of a peptide inhibitor against polyglutamine aggregation in HD. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

The nanoparticulate drug-delivery system was developed for a novel peptide inhibitor ‘PGQ9[P2]’. The in vitro characterization confirmed uniform and narrow distribution of particles below 200 nm with high entrapment of peptide. When PGQ9[P2]-loaded nanoparticles were incubated with aggregating peptide Q35P10 that represents N-terminus of Huntingtin, the released PGQ9[P2] suppressed its aggregation. These results indicate a progressive step toward the delivery of peptide inhibitor for therapeutic development in Huntington's disease.

Large scale conformational transitions in β-structural motif of gramicidin A: kinetic analysis based on CD and FT-IR data

Gramicidin A (gA) is a polypeptide antibiotic, which forms dimeric channels specific for monovalent cations in artificial and biological membranes. It is a polymorphic molecule that adopts a unique variety of helical conformations, including antiparallel double-stranded [UPWARDS ARROW][DOWNWARDS ARROW]β5.6 or [UPWARDS ARROW][DOWNWARDS ARROW]β7.2 helices (number of residues per turn) and a single-stranded β6.3 helix (the ‘channel form’). The behavior of gA-Cs+ complex in the micelles of TX-100 was studied in this work. Transfer of the complex into the micelles activates a cascade of sequential conformational transitions monitored by CD and FT-IR spectroscopy:

  • display math

At the first step after Cs+ removal, the RH [UPWARDS ARROW][DOWNWARDS ARROW]β5.6 helix is formed, which has been discussed so far only hypothetically. Kinetics of the transitions was measured, and the activation parameters were determined. The activation energies of the [UPWARDS ARROW][DOWNWARDS ARROW]β5.6 [RIGHTWARDS ARROW]β-helical monomer transition in dioxane and dioxane/water solutions were also measured for comparison. The presence of water raises the transition rate constant ~103 times but does not lead to crucial fall of the activation energy. All activation energies were found in the 20–25 kcal/mol range, i.e. much lower than would be expected for unwinding of the double helix (when 28 H-bonds are broken simultaneously). These results can be accounted for in the light of local unfolding (or ‘cracking’) model for large scale conformational transitions developed by the P. G.Wolynes team [Miyashita O, Onuchic JN, Wolynes PG. Proc. Natl. Acad. Sci. USA 2003; 100: 12570-12575.]. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

Transfer of Cs-gA complex into the TX-100 micelles and dioxane solution activates a cascade of sequential conformational transitions monitored by CD and FT-IR spectroscopy. Kinetics of the transitions was measured and the activation parameters determined. The results are discussed in the light of local unfolding, (or “cracking”) model of large scale conformational transitions.

Ornithokinin (avian bradykinin) from the skin of the Chinese bamboo odorous frog, Odorrana versabilis

One of the most widespread and abundant families of pharmacologically active peptides in amphibian defensive skin secretions is the bradykinins and related peptides. Despite retaining certain primary structural attributes that assign them to this peptide family, bradykinins and related peptides are unique among amphibian skin peptides in that they exhibit a wide range of primary structural variations, post-translational modifications and/or N-terminal or C-terminal extensions. Initially it was believed that their high degree of primary structural heterogeneity was reflective of random gene mutations within species, but latterly, there is an increasing body of evidence that the spectrum of structural modifications found within this peptide family is reflective of the vertebrate predator spectrum of individual species. Here we report the discovery of ornithokinin (avian bradykinin – Thr6, Leu8-bradykinin) in the skin secretion of the Chinese bamboo odorous frog, Odorrana versabilis. Molecular cloning of its biosynthetic precursor-encoding cDNA from a skin secretion-derived cDNA library revealed a deduced open-reading frame of 86 amino acid residues, encoding a single copy of ornithokinin towards its C-terminus. The domain architecture of this ornithokinin precursor protein was consistent with that of a typical amphibian skin peptide and quite different to that of the ornithokininogen from chicken plasma. Ornithokinin was reported to induce hypotension in the chicken and to contract the chicken oviduct but to have no obvious effect on the rat uterus. However, in this study, synthetic ornithokinin was found to contract the rat ileum (EC50 = 539 nM) and to increase contraction frequency in the rat uterus (EC50 = 1.87 μM). Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

An ornithokinin-encoding precursor protein was cloned form the skin secretion of the Chinese bamboo odorous frog, Odorrana versabilis. Its structure was consistent with a typical amphibian skin peptide precursor and was quite different from chicken ornithokininogen.

Deletion of the carboxyl-terminal residue disrupts the amino-terminal folding, self-association, and thermal stability of an amphipathic antimicrobial peptide

Understanding the complex relationship between amino acid sequence and protein behaviors, such as folding and self-association, is a major goal of protein research. In the present work, we examined the effects of deleting a C-terminal residue on the intrinsic properties of an amphapathic α-helix of mastoparan-B (MP-B), an antimicrobial peptide with the sequence LKLKSIVSWAKKVL-NH2. We used circular dichroism and nuclear magnetic resonance to demonstrate that the peptide MP-B[1-13] displayed significant unwinding at the N-terminal helix compared with the parent peptide of MP-B, as the temperature increased when the residue at position 14 was deleted. Pulsed-field gradient nuclear magnetic resonance data revealed that MP-B forms a larger diffusion unit than MP-B[1-13] at all experimental temperatures and continuously dissociates as the temperature increases. In contrast, the size of the diffusion unit of MP-B[1-13] is almost independent of temperature. These findings suggest that deleting the flexible, hydrophobic amino acid from the C-terminus of MP-B is sufficient to change the intrinsic helical thermal stability and self-association. This effect is most likely because of the modulation of enthalpic interactions and conformational freedom that are specified by this residue. Our results implicate terminal residues in the biological function of an antimicrobial peptide. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

The roles of the C-terminal residue in peptide behaviors were examined. The association size of the peptides and their structures at various temperatures in 2,2,2-trifluoroethanol aqueous solution were monitored and characterized with nuclear magnetic resonance methods. The structural and functional relevance of the terminus demonstrated in this work is potentially relevant for the design of potent substances that may serve as drug candidates.

On the limited recognition of inorganic surfaces by short peptides compared with antibodies

The vast potential applications of biomolecules that bind inorganic surfaces led mostly to the isolation of short peptides that target selectively specific materials. The demonstrated differential affinity toward certain surfaces created the impression that the recognition capacity of short peptides may match that of rigid biomolecules. In the following, we challenge this view by comparing the capacity of antibody molecules to discriminate between the (100) and (111A) facets of a gallium arsenide semiconductor crystal with the capacity of short peptides to do the same. Applying selection from several peptide and single chain phage display libraries, we find a number of antibody molecules that bind preferentially a given crystal facet but fail to isolate, in dozens of attempts, a single peptide capable of such recognition. The experiments underscore the importance of rigidity to the recognition of inorganic flat targets and therefore set limitations on potential applications of short peptides in biomimetics. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

The vast potential applications of biomolecules that bind inorganic surfaces led mostly to the isolation of short peptides that target selectively specific materials. Here, we challenge this trend by comparing the capacity of antibody molecules to peptides. The experiments underscore the importance of rigidity to the recognition of inorganic flat targets and therefore set limitations on potential applications of short peptides in biomimetics.

Self-assembling amphiphilic peptides

The self-assembly of several classes of amphiphilic peptides is reviewed, and selected applications are discussed. We discuss recent work on the self-assembly of lipopeptides, surfactant-like peptides and amyloid peptides derived from the amyloid-β peptide. The influence of environmental variables such as pH and temperature on aggregate nanostructure is discussed. Enzyme-induced remodelling due to peptide cleavage and nanostructure control through photocleavage or photo-cross-linking are also considered. Lastly, selected applications of amphiphilic peptides in biomedicine and materials science are outlined. © 2014 The Authors. Journal of Peptide Science published by European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

The self-assembly of amphiphilic peptides including surfactant-like peptides and lipopeptides is reviewed, focusing on modes and mechanisms of self-assembly as well as applications in biomedicine and materials science.

Potent inhibitors of human matriptase-1 based on the scaffold of sunflower trypsin inhibitor

Sunflower trypsin inhibitor-1 (SFTI-1), a bicyclic tetradecapeptide, has become a versatile tool as a scaffold for the development of the inhibitors of therapeutically relevant serine proteases, among them matriptase and kallikreins. Herein, we report the rational design of potent monocyclic and bicyclic inhibitors of human matriptase-1. We found that the presence of positive charge and lack of bulky residues at the peptide N-terminus is required for the maintenance of inhibitory activity. Replacement of the N-terminal glycine residue by lysine allowed for the chemical conjugation with a fluorophor via the ε-amino group without significant loss of inhibitory activity. Head-to-tail and side-chain-to-tail cyclization resulted in potent inhibitors with comparable activities against matriptase-1. The most potent synthetic bicyclic inhibitor found in this study (Ki = 2.6 nM at pH 7.6) is a truncated version of SFTI-1 (cyclo-KRCTKSIPPRCH) lacking a C-terminal proline and aspartate residue. It combines an internal disulfide bond with a peptide macrocycle that is formed through side-chain-to-tail cyclization of the ε-amino group of an N-terminal lysine and a C-terminal proline. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

We report the rational design, synthesis, and biological activity of potent monocyclic and bicyclic peptidic inhibitors of human matriptase-1 based on an improved variant of the sunflower trypsin inhibitor-1. The activity of the resulted synthetic variants against cancer-related human matriptase-1 was examined in order to evaluate the influence of structural elements, e.g. cyclic backbone, chain length, and bulky substituents. The most potent inhibitors showed activity against matriptase-1 in single-digit nanomolar range (Ki = 2.1 nM).

Antioxidant properties of a human neuropeptide and its protective effect on free radical-induced DNA damage

Human catestatin CgA352–372 (SL21) is an endogenous neuropeptide with multiple biological functions. The present study aimed to evaluate the antioxidant, antibacterial, cytotoxic, and DNA damage protective effects of SL21 neuropeptide. SL21 neuropeptide generated from the C-terminus of chromogranin A (CgA) was synthesized by solid-phase method. Synthetic peptide was subjected to various in vitro antioxidant assays including the scavenging of 1,1-diphenyl-2-pycryl-hydrazyl (DPPH), 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS·+), and hydroxyl free radicals, metal ion chelation, inhibition of lipid peroxidation, and reducing power. Moreover, protective effect of SL21 on H2O2-induced DNA damage was analyzed using pTZ57/RT plasmid. Methylthiazoltetrazolium assay was also performed to study the cytotoxic effect of SL21 neuropeptide on human peripheral blood mononuclear cells. Furthermore, antibacterial and hemolysis assays were conducted. The results demonstrated high activities of SL21 in scavenging free radicals (DPPH, ABTS·+, and hydroxyl), chelating of Cu2+/Fe2+ metal ions, reducing power, and inhibition of lipid peroxidation in a concentration-dependent manner. SL21 neuropeptide revealed a protective effect on DNA damage caused by hydroxyl radicals. Interestingly, the peptide exhibited no significant cytotoxicity towards peripheral blood mononuclear cells. Furthermore, SL21 peptide displayed antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa without any hemolytic activity on human red blood cells. Conclusively, the present study established SL21 (catestatin) as a novel antioxidative peptide that could further be investigated for its potential use as a pharmaceutical agent. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

Antioxidant capacity of SL21, a human neuropeptide, was evaluated on the basis of its ability to quench several free radicals including DPPH, ABTS, and H2Os as well as lipid peroxidation inhibition and metal ion chelating assays. The protecting property against oxidative-mediated DNA damage was also investigated.

Structure-activity relationship of Trp-containing analogs of the antimicrobial peptide gomesin

Gomesin (Gm) has a broad antimicrobial activity making it of great interest for development of drugs. In this study, we analyzed three Gm analogs, [Trp1]-Gm, [Trp7]-Gm, and [Trp9]-Gm, in an attempt to gain insight into the contributions of different regions of the peptide sequence to its activity. The incorporation of the tryptophan residue in different positions has no effect on the antimicrobial and hemolytic activities of the Gm analogs in relation to Gm. Spectroscopic studies (circular dichroism, fluorescence and absorbance) of Gm and its analogs were performed in the presence of SDS, below and above its critical micelle concentration (CMC) (~8 mM), in order to monitor structural changes induced by the interaction with this anionic surfactant (0–15 mM). Interestingly, we found that the analogs interact more strongly with SDS at low concentrations (0.3-6.0 mM) than close to or above its CMC. This suggests that SDS monomers are able to cover the whole peptide, forming large detergent-peptide aggregates. On the other hand, the peptides interact differently with SDS micelles, inserting partially into the micelle core. Among the peptides, Trp in position 1 becomes more motionally-restricted in the presence of SDS, probably because this residue is located at the N-terminal region, which presents higher conformational freedom to interact stronger with SDS molecules. Trp residues in positions 7 and 9, close to and in the region of the turn of the molecule, respectively, induced a more constrained structure and the compounds cannot insert deeper into the micelle core or be completely buried by SDS monomers. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

Thumbnail image of graphical abstract

Gomesin has 18 amino acid residues and shows high antimicrobial activity against pathogens and model membranes. Spectroscopic studies of Gm and its analogs were carried out in the presence of SDS, below and above its CMC. We found that all analogs interact more strongly with SDS below its CMC, suggesting that SDS monomers are able to cover the whole peptide. Among the peptides, Trp in position 1, located at the N-terminal region, becomes more motionally-restricted in the presence of SDS.


s2Member®
loading...